P/E at 64.27 vs Industry's 63.15: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Slight Premium in a High-P/E Sector

The current P/E of 64.27 for Apollo Hospitals Enterprise Ltd. sits just above the hospital industry’s average of 63.15, indicating investors are willing to pay a modest premium for the stock. This premium suggests confidence in the company’s earnings growth relative to peers, though the difference is not substantial enough to signal an extreme valuation divergence. The sector itself commands elevated multiples, reflecting the growth potential and defensive qualities associated with healthcare services.

Given the narrow gap between the stock’s P/E and the industry average, the valuation appears aligned with sector fundamentals rather than disconnected from market realities. However, Apollo Hospitals remains priced at a level that demands consistent earnings delivery to justify this premium — previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in the valuation premium.

Performance Across Timeframes: Consistent Outperformance

Examining returns over various periods reveals a strong performance profile for Apollo Hospitals. The stock has gained 16.36% over the last year, significantly outpacing the Sensex’s 6.43% loss. This outperformance extends to shorter intervals as well, with a 3-month return of 20.15% compared to the Sensex’s 6.23%, and a 1-month gain of 6.12% versus the benchmark’s 4.76%. Year-to-date, the stock has surged 24.82%, while the Sensex has declined 8.61%, underscoring the stock’s resilience amid broader market weakness.

Even on a daily and weekly basis, Apollo Hospitals has outperformed, with a 1-day gain of 1.07% against the Sensex’s 0.49%, and a 1-week rise of 2.30% compared to 1.02% for the index. This consistent alpha generation across timeframes highlights the stock’s relative strength within the hospital sector — is this momentum sustainable or a peak in performance?

Moving Average Configuration: Bullish Across All Key Averages

The technical picture for Apollo Hospitals is notably positive, with the stock trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This alignment across short, medium, and long-term averages signals a strong uptrend and suggests broad-based buying interest. The stock is currently just 0.67% shy of its 52-week high of ₹8,758, indicating it is near peak levels for the past year.

Such a configuration is often interpreted as a confirmation of trend strength, reducing the likelihood of a near-term reversal. The stock’s recent two-day consecutive gains, amounting to a 0.97% rise, further reinforce this momentum. The fact that it opened and traded steadily at ₹8,700.1 today reflects a stable price environment — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Sector Context: Hospital Industry Showing Mixed but Generally Positive Trends

The hospital sector, within which Apollo Hospitals operates, has exhibited a broadly positive performance trend recently. While exact sector-wide figures are not detailed here, the industry’s P/E of 63.15 reflects elevated valuations consistent with growth expectations. The sector’s performance has been supported by increasing healthcare demand and expanding service offerings.

Within this context, Apollo Hospitals stands out for its consistent outperformance relative to the Sensex and its peers. The stock’s ability to maintain a premium valuation while delivering superior returns suggests it is capturing a favourable position in the sector — should investors in Apollo Hospitals hold, buy more, or reconsider?

Rating Context: Previously Rated Hold, Now Reassessed

MarketsMOJO had previously assigned a Hold rating to Apollo Hospitals Enterprise Ltd.. This rating was updated on 11 May 2026, reflecting a reassessment based on recent performance, valuation, and technical factors. The company’s Mojo Score stands at 78.0, indicative of a strong overall profile within its large-cap hospital sector.

The rating update aligns with the stock’s sustained outperformance and positive technical signals, though the precise current rating is not disclosed here. This reassessment underscores the importance of monitoring evolving data points — what is the current rating for Apollo Hospitals Enterprise Ltd.?

Conclusion: Data Reflects a Stock in Strong Form with a Slight Valuation Premium

The comprehensive data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a modest premium to its sector’s P/E, supported by consistent outperformance across multiple timeframes and a bullish technical setup. The stock’s position above all key moving averages and proximity to its 52-week high reinforce the strength of its current trend.

While the valuation premium is not excessive, it does imply expectations for continued earnings growth and operational resilience. The sector’s generally positive environment further supports this stance. The recent rating reassessment from Hold reflects these evolving fundamentals and technical factors — should investors in Apollo Hospitals hold, buy more, or reconsider?